ReviewZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
[Advances in the application of the HEART score in patients with acute coronary syndromes].
Review in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute coronary syndromes (ACS) are among the most critical cardiovascular emergencies in clinical practice. Rapid identification, accurate risk stratification, and early intervention are essential for improving patient outcomes. The HEART score, which consists of 5 core components, History (H), Electrocardiogram (E), Age (A), Risk factors (R), and Troponin (T), is an important tool for risk assessment and stratified management of patients presenting to the emergency department with chest pain. Owing to its simplicity, efficiency, and strong evidence base, the HEART score has been recommended by chest pain management guidelines in multiple countries. This review systematically summarizes the advances in the application of the HEART score in patients with ACS. The composition of the score, grading criteria, and emergency department workflow are described in detail. Particular emphasis is placed on its clinical value in the early diagnosis, risk stratification, therapeutic decision‑making, and prognostic assessment of ACS. In addition, the applicability and performance of the HEART score are compared with those of other commonly used risk assessment tools. The limitations of the HEART score, including limited capability for dynamic monitoring, susceptibility to subjective bias, applicability in special populations, and challenges in localized implementation, are also discussed. Furthermore, future directions for dynamic, intelligent, and localized modifications of the HEART score are proposed. This review may provide a reference for the more scientific, standardized, and efficient application of the HEART score in emergency and cardiovascular medicine in China, thereby facilitating early screening, precise triage, and optimized management of patients with ACS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.